46 related articles for article (PubMed ID: 7480892)
1. Alternative models for low dose-response analysis of biochemical and immunological endpoints for tetrachlorodibenzo-p-dioxin.
McGrath LF; Cooper KR; Georgopoulos P; Gallo MA
Regul Toxicol Pharmacol; 1995 Jun; 21(3):382-96. PubMed ID: 7480892
[TBL] [Abstract][Full Text] [Related]
2. 2,3,7,8,-Tetrachlorodibenzo-p-dioxin: segregation of toxocity with the Ah locus.
Poland A; Glover E
Mol Pharmacol; 1980 Jan; 17(1):86-94. PubMed ID: 7383021
[No Abstract] [Full Text] [Related]
3. Application of a biologically-based RFD estimation method to tetrachlorodibenzo-p-dioxin (TCDD) mediated immune suppression and enzyme induction.
McGrath LF; Georgopoulos P; Gallo MA
Risk Anal; 1996 Aug; 16(4):539-48. PubMed ID: 8819344
[TBL] [Abstract][Full Text] [Related]
4. Dioxin-responsive genes: examination of dose-response relationships using quantitative reverse transcriptase-polymerase chain reaction.
Vanden Heuvel JP; Clark GC; Kohn MC; Tritscher AM; Greenlee WF; Lucier GW; Bell DA
Cancer Res; 1994 Jan; 54(1):62-8. PubMed ID: 8261464
[TBL] [Abstract][Full Text] [Related]
5. Relationship between CYP1A enzyme activities and protein levels in rats treated with 2,3,7,8-tetrachlorodibenzo-p-dioxin.
DeVito MJ; Beebe LE; Menache M; Birnbaum LS
J Toxicol Environ Health; 1996 Mar; 47(4):379-94. PubMed ID: 8600290
[TBL] [Abstract][Full Text] [Related]
6. Toxicology and carcinogenesis studies of a mixture of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) (Cas No. 1746-01-6), 2,3,4,7,8-pentachlorodibenzofuran (PeCDF) (Cas No. 57117-31-4), and 3,3',4,4',5-pentachlorobiphenyl (PCB 126) (Cas No. 57465-28-8) in female Harlan Sprague-Dawley rats (gavage studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 2006 Sep; (526):1-180. PubMed ID: 17342195
[TBL] [Abstract][Full Text] [Related]
7. Rainbow trout hepatic mixed-function oxygenase induction by polychlorinated dibenzo-p-dioxins (PCDDs) as a function of time and tissue concentration.
Parrott JL; Hodson PV; Dixon DG
J Toxicol Environ Health; 1995 Nov; 46(3):301-16. PubMed ID: 7473859
[TBL] [Abstract][Full Text] [Related]
8. Correlation between toxicity and effects on intermediary metabolism in 2,3,7,8-tetrachlorodibenzo-p-dioxin-treated male C57BL/6J and DBA/2J mice.
Weber LW; Lebofsky M; Stahl BU; Smith S; Rozman KK
Toxicol Appl Pharmacol; 1995 Mar; 131(1):155-62. PubMed ID: 7878671
[TBL] [Abstract][Full Text] [Related]
9. Dose-response relationships of tissue distribution and induction of CYP1A1 and CYP1A2 enzymatic activities following acute exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in mice.
Diliberto JJ; Akubue PI; Luebke RW; Birnbaum LS
Toxicol Appl Pharmacol; 1995 Feb; 130(2):197-208. PubMed ID: 7871533
[TBL] [Abstract][Full Text] [Related]
10. Dexamethasone, beta-estradiol, and 2,3,7,8-tetrachlorodibenzo-p-dioxin elicit thymic atrophy through different cellular targets.
Silverstone AE; Frazier DE; Fiore NC; Soults JA; Gasiewicz TA
Toxicol Appl Pharmacol; 1994 Jun; 126(2):248-59. PubMed ID: 7516097
[TBL] [Abstract][Full Text] [Related]
11. Mechanistic modeling of rodent liver tumor promotion at low levels of exposure: an example related to dose-response relationships for 2,3,7,8-tetrachlorodibenzo-p-dioxin.
Andersen ME; Conolly RB
Hum Exp Toxicol; 1998 Dec; 17(12):683-90; discussion 701-4, 708-18. PubMed ID: 9988373
[No Abstract] [Full Text] [Related]
12. Lymphocyte stem cell alterations following perinatal exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin.
Fine JS; Gasiewicz TA; Silverstone AE
Mol Pharmacol; 1989 Jan; 35(1):18-25. PubMed ID: 2783621
[TBL] [Abstract][Full Text] [Related]
13. Dose-response relationships for chronic exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin in a rat tumor promotion model: quantification and immunolocalization of CYP1A1 and CYP1A2 in the liver.
Tritscher AM; Goldstein JA; Portier CJ; McCoy Z; Clark GC; Lucier GW
Cancer Res; 1992 Jun; 52(12):3436-42. PubMed ID: 1596902
[TBL] [Abstract][Full Text] [Related]
14. NTP technical report on the toxicology and carcinogenesis studies of 2,2',4,4',5,5'-hexachlorobiphenyl (PCB 153) (CAS No. 35065-27-1) in female Harlan Sprague-Dawley rats (Gavage studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 2006 May; (529):4-168. PubMed ID: 16835634
[TBL] [Abstract][Full Text] [Related]
15. Impairment of prothymocyte activity by 2,3,7,8-tetrachlorodibenzo-p-dioxin.
Fine JS; Silverstone AE; Gasiewicz TA
J Immunol; 1990 Feb; 144(4):1169-76. PubMed ID: 2303704
[TBL] [Abstract][Full Text] [Related]
16. The toxicokinetics of 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin in mammalian systems.
Neal RA; Olson JR; Gasiewicz TA; Geiger LE
Drug Metab Rev; 1982; 13(3):355-85. PubMed ID: 7049640
[No Abstract] [Full Text] [Related]
17. Toxicology and carcinogenesis studies of 2,3,4,7,8-pentachlorodibenzofuran (PeCDF) (Cas No. 57117-31-4) in female Harlan Sprague-Dawley rats (gavage studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 2006 Sep; (525):1-198. PubMed ID: 17160103
[TBL] [Abstract][Full Text] [Related]
18. NTP toxicology and carcinogenesis studies of 3,3',4,4',5-pentachlorobiphenyl (PCB 126) (CAS No. 57465-28-8) in female Harlan Sprague-Dawley rats (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 2006 Jan; (520):4-246. PubMed ID: 16628245
[TBL] [Abstract][Full Text] [Related]
19. Prothymocyte activity is reduced by perinatal 2,3,7,8-tetrachlorodibenzo-p-dioxin exposure.
Fine JS; Gasiewicz TA; Fiore NC; Silverstone AE
J Pharmacol Exp Ther; 1990 Oct; 255(1):128-32. PubMed ID: 2213547
[TBL] [Abstract][Full Text] [Related]
20. [Acute toxicity, inductive effects of liver enzymes and distribution in the liver of 1,2,3,7,8-pentachlorodibenzo-p-dioxin in rats].
Koga N; Kuroki J; Nakashima H; Hokama-Kuroki Y; Yoshimura H; Kuroki H; Masuda Y
Fukuoka Igaku Zasshi; 1991 May; 82(5):197-206. PubMed ID: 1916588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
